Multiomics-based Drug Discovery And Development: Emerging Opportunities & Competitive Landscape

Table of Contents

Chapter 1. Overview of Multiomics in Drug Discovery & Development
                    1.1 Historical Developments
                    1.2. Comparison with Traditional Drug Discovery & Development Methods
                    1.3. Regulatory Landscape Overview
Chapter 2. Key Omics Modalities and Integration Approaches
                    2.1. Genomics and Epigenomics
                    2.2. Transcriptomics
                    2.3. Proteomics
                    2.4. Metabolomics
                    2.5. Multiomics Integration and Systems Biology
Chapter 3. Emerging Technologies and Innovations
                    3.1. Single-cell Multiomics
                    3.2. AI & Machine Learning in Multiomics
                    3.3. Spatial Omics Technologies
                    3.4. Proteogenomics
                    3.5. Cloud-based and Open Science Platforms
Chapter 4. Application Landscape
                    4.1. Target and Biomarker Discovery
                    4.2. Patient Stratification and Precision Medicine
                    4.3. Mechanism of Action Studies
                    4.4. Clinical Trial Design Optimization
                    4.5. Companion Diagnostics
Chapter 5. Competitive Analysis of Key Players
                    5.1. Company Profiles (The parameters below will be analyzed for the top 15 companies only)
                       5.1.1. Company Overview
                           5.1.1.1. Headquarters
                           5.1.1.2. Establishment Year
                           5.1.1.3. Employee Strength
                           5.1.1.4. Company Type/Ownership Information
                           5.1.1.5. Business Verticals
                           5.1.1.6. Business Overview
                       5.1.2. Product/Service Benchmarking
                       5.1.3. Financial Performance (Only for Public Companies)
                           5.1.3.1. Revenue
                           5.1.3.2. Operating Income/Loss
                           5.1.3.3. EBIT/EBITA
                           5.1.3.4. Net Income/Loss
                       5.1.4. Strategic Initiatives
                       5.1.5. SWOT Analysis